Purchases and Sales Made in Q1 2025 in Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID) during Q1 2025. The information is specifically focused on institutions that hold shares of Ovid Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-93.7K- 47.29% |
$29K - $89.9K
|
104K
$43.9K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-107K- 56.34% |
$33.1K - $102K
|
82.7K
$34.7K
|
|
|
May 15, 2025
Q1 2025
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-134K- 58.35% |
$41.4K - $128K
|
95.4K
$40.1K
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-210K- 14.78% |
$65K - $201K
|
1.21M
$508K
|
|
|
May 15, 2025
Q1 2025
|
Madison Avenue Partners, LP
New York, NY |
SELL
|
- |
-1.26M- 33.77% |
$390K - $1.21M
|
2.47M
$1.04M
|